Applications of single-molecule protein sequencing in precision oncology drug development
December 12, 2025
Protein variant characterization remains a central challenge in precision oncology, where understanding the functional consequences of sequence alterations can inform and drive therapeutic development.
In this webcast, Dr Nigel O’Neil, Co-Founder and CSO of Arrowsmith Genetics, will discuss his team’s work in oncology drug development, highlighting the technical and biological hurdles encountered when working with conventional protein analysis workflows. He will share how he has applied next-gen protein sequencing on the Platinum Pro to explore protein variation, interactions, and function.
Speakers: Dr. Nigel O’Neil, Co-Founder and CSO of Arrowsmith Genetics
Moderator: Nikki Forrester, Workcast
Date: December 10, 2025